Larvol Delta - AfniT-Therapeutics-to-Present-AFNT211-T-Cell-Product-Attributes-Targeting-KRAS-G12V-at-the-2023-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting

AFNT-211 - Affini-T Therap

https://www.businesswire.com/news/home/20230525005828/en/Affini-T-Therapeutics-to-Present-AFNT-211-T-Cell-Product-Attributes-Targeting-KRAS-G12V-at-the-2023-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting

May 25, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next